Related Experiment Videos

Functional Status and Health-Related Quality of Life Among Survivors of Cardiogenic Shock

Eric J Hall1, Sachin Agarwal2, Colby R Ayers3

  • 1Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA; Parkland Health and Hospital System, Dallas, Texas, USA.

JACC. Heart Failure
|July 18, 2026
PubMed

Insights

Cardiogenic shock (CS) survivors face significant functional disability and lower quality of life post-discharge. Pain and mobility issues are common, highlighting the need for improved recovery strategies.

Area of Science:

  • Cardiology
  • Patient-centered outcomes research
  • Quality of life studies

Background:

  • Limited data exist on patient-centered outcomes for cardiogenic shock (CS) survivors post-discharge.
  • Functional status and health-related quality of life (HRQoL) are critical but understudied aspects of CS recovery.

Purpose of the Study:

  • To evaluate patient-centered outcomes, including functional status and HRQoL, in survivors of cardiogenic shock (CS).

Main Methods:

  • Prospective cohort study of CS survivors (Society of Coronary Angiography and Intervention Stage C or greater).
  • Primary outcome: functional disability at 3 months (modified Rankin Scale ≥2).
  • Secondary outcome: HRQoL assessed via EQ-5D at 3 months.

Main Results:

  • 118 CS survivors completed 3-month follow-up; 46% experienced functional disability.
  • Common issues included pain (67%), mobility limitations (48%), and anxiety/depression (35%).
  • Median EQ-5D Index Score (0.84) was below US population norms; functional status correlated inversely with HRQoL (r = -0.68).

Conclusions:

  • CS survivors exhibit substantial functional limitations and diminished HRQoL up to 3 months post-discharge.
  • Pain and mobility impairments are prevalent, impacting overall recovery.
  • Further research is needed to optimize multidomain recovery strategies for CS survivors.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...